)
Visual
earnings real time
TransMedics Group
TransMedics Group (TMDX) investor relations material
TransMedics Group 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary12 Jan, 2026
Strategic Vision, Technology Innovation, and Conference Insights
Relocation to a new Somerville facility is planned within 12–18 months to support growth initiatives.
OCS platforms for lung, heart, and liver are FDA-approved, with kidney entering clinical trials by late 2024 or early 2025; Gen-3 OCS and kidney expected by 2029+.
OCS is the only multiorgan, portable warm perfusion system, supporting heart, lung, liver, and kidney transplants.
Gen-3 OCS Kidney introduces smaller, automated, remotely monitored technology with real-time viability assessment; upgrades for other organs will follow.
The digital ecosystem and command center provide real-time logistics, clinical, and financial transparency for transplant centers.
Clinical Evidence and Market Expansion
OCS platforms are supported by Level 1 FDA pivotal trials and the largest body of prospective clinical evidence for DBD and DCD organs.
ENHANCE (heart) and DENOVO (lung) trials are underway, aiming for superiority claims over cold storage; DENOVO trial received unconditional FDA approval.
Heart trial enrollment is progressing, with full enrollment expected in 12–18 months; lung may take closer to 18 months.
Liver adoption is expected to accelerate with upcoming publications from a registry of over 9,000 transplants.
OCS technology minimizes ischemic damage, enables ex-vivo organ optimization, and provides real-time clinical assessment.
Operational Scale, NOP, and Logistics Integration
The National OCS Program (NOP) operates from 18 U.S. hubs, with 50+ transplant surgeons, 200+ clinical specialists, 22 airplanes, and a digital ecosystem.
TransMedics Aviation manages 22 aircraft and 130+ pilots, enabling rapid, long-range organ transport.
NOP operates a 24/7 logistics command center with advanced routing technology and 90 full-time employees.
NOP and OCS have driven mid-20% annual growth in U.S. heart, lung, and liver transplant volumes over three years, with high utilization rates.
DCD organ utilization has increased over 500% since OCS FDA approvals.
Assess NOP aviation and pilot retention strategy
Evaluate OCS Kidney and next-gen OCS impact
Analyze Italy NOP model's scalability for EU
How does the digital ecosystem scale internationally?
What is the strategy for Gen-2 trial superiority claims?
How will OCS Kidney address 10k rejected kidneys?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 323410
Strong growth in customers, profits, and deposits, with stable asset quality and global milestones. - 3407
Net income rose 22.7% year-over-year, with improved financials and a revised upward forecast. - RYM
Refreshed strategy targets NZD 150m cash flow uplift, NZD 500m cash release, and resumed dividends by FY 2028. - 9101
Profits fell across most segments, but energy shipping and a major acquisition stood out. - 4626
Double-digit profit and sales growth, with strong segment results and a stock split impact. - 2371
Revenue up 21.5% YoY, but profit down on higher investments; LiPLUS Holdings acquired. - 3401
Major impairments and divestitures led to a net loss and lower revenue across all segments. - 8002
Profit forecast raised to ¥540.0B and annual dividend to ¥107.50 per share after strong results. - COF
Profit rebounded, NTA and occupancy rose, with strong leasing and premium divestment. - NUF
Statutory loss reported, seeds business repositioned, new CEO appointed, all resolutions passed.
Next TransMedics Group earnings date
Q4 202526 Feb, 2026
TransMedics Group
Next TransMedics Group earnings date
Q4 202526 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. It develops Organ Care System platform that enables the assessment of donor organ viability, the maintenance of donor organ function, and intervention in the organ procurement process for use in lung, heart, kidney and liver transplantations.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage